Vimarsana
Biggest News Aggregation in the World

Page 16 - Procaps Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Procaps Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Procaps Group Today - Breaking & Trending Today

Procaps Group Reports Second Quarter and First Half 2022 Results - Vimarsana News

Procaps Group Reports Second Quarter and First Half 2022 Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
FinancialNewsMedia.com: R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions - Vimarsana News

FinancialNewsMedia.com: R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 29, 2022 /PRNewswire/ -- In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies

R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions - Vimarsana News

R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions

/PRNewswire/ -- In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies are highly investing in the development of...

Procaps Group (NASDAQ:PROC) Upgraded to Hold at Zacks Investment Research - Vimarsana News

Procaps Group (NASDAQ:PROC) Upgraded to Hold at Zacks Investment Research

Procaps Group (NASDAQ:PROC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets […]

Research Analysts' Upgrades for June 10th (ARZTF, CMCSA, CME, CUSPY, DBMBF, EQT, FDS, FTUAF, FUTU, GRC) - Vimarsana News

Research Analysts' Upgrades for June 10th (ARZTF, CMCSA, CME, CUSPY, DBMBF, EQT, FDS, FTUAF, FUTU, GRC)

Research Analysts’ upgrades for Friday, June 10th: Aryzta (OTCMKTS:ARZTF) was upgraded by analysts at Cheuvreux to a hold rating. Comcast (NASDAQ:CMCSA) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. CME Group (NASDAQ:CME) was upgraded by analysts at Atlantic Securities from a neutral rating to an overweight rating. The firm […]